anti slc3a2 (Cell Signaling Technology Inc)
97
Structured Review
Cell Signaling Technology Inc
anti slc3a2
Anti Slc3a2, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 834 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+slc3a2/HIF-1alpha+XP+Rabbit+mAb/pm41894392-381-15-16
Average 97 stars, based on 834 article reviews
Anti Slc3a2, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 834 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+slc3a2/HIF-1alpha+XP+Rabbit+mAb/pm41894392-381-15-16
Average 97 stars, based on 834 article reviews
anti slc3a2 - by Bioz Stars,
2026-09
97/100 stars
Images
Related Articles
other:Article Title: SLC13A3 is a major effector downstream of activated β-catenin in liver cancer pathogenesis Article Snippet: Several critical antibodies such as SLC13A3, -Catenin, c-MYC and SLC7A5 were validated using either over-expressing or knockdown cell lines in this study. anti-SLC13A3 (Abcam, #Ab56017): Identification of 54 kD band in WB using whole Jurkat cell lysate. Incubation:Article Title: Disulfidptosis-related gene SLC3A2: a novel prognostic biomarker in nasopharyngeal carcinoma and head and neck squamous cell carcinoma Article Snippet: The isolated proteins were transferred from the gel to a polyvinylidene fluoride (PVDF) membrane (Merck Millipore) and blocked with 5% skim milk for one hour at room temperature. .. The blots were cut and then incubated with the primary antibodies of Article Title: Anaplastic Lymphoma Kinase signaling stabilizes SLC3A2 expression via MARCH11 to promote neuroblastoma cell growth. Article Snippet: NB1 cells were treated with ALKAL2 (1 μg/ml) or/and lorlatinib (30 nM) or/ and MG132 (10 μM), CLB-GE and CLB-BAR cells were treated with lorlatinib (30 nM) for 24 h prior to lysis with IP buffer (150mM NaCl, 50 mM Tris-HCl, 1% Triton X-100, 1% glycerol) containing protease inhibitor cocktail (#04693132001, Roche). .. Either 3 μg anti-ALK (#3633, CST), Article Title: Anaplastic Lymphoma Kinase signaling stabilizes SLC3A2 expression via MARCH11 to promote neuroblastoma cell growth Article Snippet: NB1 cells were treated with ALKAL2 (1 μg/ml) or/and lorlatinib (30 nM) or/and MG132 (10 μM), CLB-GE and CLB-BAR cells were treated with lorlatinib (30 nM) for 24 h prior to lysis with IP buffer (150 mM NaCl, 50 mM Tris-HCl, 1% Triton X-100, 1% glycerol) containing protease inhibitor cocktail (#04693132001, Roche). .. Either 3 μg anti-ALK (#3633, CST), Western Blot:Article Title: Phase Separation of NFIB Suppresses SLC3A2-Mediated Ferroptosis in Castration-Resistant Prostate Cancer. Article Snippet: .. The primary antibodies used in Western blotting included anti-NFIB (1:1000, Abcam), Article Title: Metformin Reprograms Tryptophan Metabolism to Stimulate CD8+ T-cell Function in Colorectal Cancer Article Snippet: .. The following antibodies were used for Western blotting: Control:Article Title: Anaplastic Lymphoma Kinase signaling stabilizes SLC3A2 expression via MARCH11 to promote neuroblastoma cell growth. Article Snippet: NB1 cells were treated with ALKAL2 (1 μg/ml) or/and lorlatinib (30 nM) or/ and MG132 (10 μM), CLB-GE and CLB-BAR cells were treated with lorlatinib (30 nM) for 24 h prior to lysis with IP buffer (150mM NaCl, 50 mM Tris-HCl, 1% Triton X-100, 1% glycerol) containing protease inhibitor cocktail (#04693132001, Roche). .. Either 3 μg anti-ALK (#3633, CST), Article Title: Anaplastic Lymphoma Kinase signaling stabilizes SLC3A2 expression via MARCH11 to promote neuroblastoma cell growth Article Snippet: NB1 cells were treated with ALKAL2 (1 μg/ml) or/and lorlatinib (30 nM) or/and MG132 (10 μM), CLB-GE and CLB-BAR cells were treated with lorlatinib (30 nM) for 24 h prior to lysis with IP buffer (150 mM NaCl, 50 mM Tris-HCl, 1% Triton X-100, 1% glycerol) containing protease inhibitor cocktail (#04693132001, Roche). .. Either 3 μg anti-ALK (#3633, CST), |